Beneficial ownership — 13D / 13G
87,281 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| HARRIS ASSOCIATES L P | CNH CNH Industrial N.V. | 13G/A | 12.06% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | APLS Apellis Pharmaceuticals, Inc. | 13G | 5.3% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | UTMD Utah Medical Products Inc | 13G/A | 7.4% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | BAH Booz Allen Hamilton Holding Corp | 13G/A | 7.8% | Dec 31, 2023 | 2y |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | MODV ModivCare Inc. Common Stock | 13G | 5% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | ELDN Eledon Pharmaceuticals, Inc. | 13G | 9.99% | Dec 31, 2023 | 2y |
| ArrowMark Colorado Holdings LLC | MNTV Momentive Global Inc. Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | RPID Rapid Micro Biosystems, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Commodore Capital LP | CABA Cabaletta Bio, Inc. | 13G/A | 4.4% | Dec 31, 2023 | 2y |
| Nantahala Capital Management, LLC | ELUT Elutia Inc. | 13G | 9.9% | Dec 31, 2023 | 2y |
| ALLIANCEBERNSTEIN L.P. | SBFG Sb Financial Group, Inc. | 13G/A | 8.4% | Dec 31, 2023 | 2y |
| Venrock Healthcare Capital Partners II, L.P. | ANNX Annexon, Inc. | 13G/A | 1.2% | Dec 31, 2023 | 2y |
| Caledonia (Private) Investments Pty Ltd | TRUE TrueCar, Inc. | 13G/A | 20.23% | Dec 31, 2023 | 2y |
| RTW INVESTMENTS, LP | ACET Adicet Bio, Inc. | 13G/A | 9.6% | Dec 31, 2023 | 2y |
| Joshua Bernstein | CBNK Capital Bancorp Inc | 13G/A | 6.22% | Dec 31, 2023 | 2y |
| MOORE CAPITAL MANAGEMENT, LP | ACAQ Athena Consumer Acquisition Corp. | 13G/A | 0% | Dec 31, 2023 | 2y |
| GLAZER CAPITAL, LLC | DIST Distoken Acquisition Corporation Ordinary Shares | 13G | 5.56% | Dec 31, 2023 | 2y |
| MGF Trust | VTEX Vtex | 13G/A | 28.5% | Dec 31, 2023 | 2y |
| Jonathan Hyman | BRZE Braze, Inc. | 13G/A | 2.6% | Dec 31, 2023 | 2y |
| Redmile Group, LLC | ANNX Annexon, Inc. | 13G/A | 9.9% | Dec 31, 2023 | 2y |
| ALLIANCEBERNSTEIN L.P. | EYE National Vision Holdings, Inc. | 13G/A | 0.1% | Dec 31, 2023 | 2y |
| Blue Owl Capital Holdings LP | LRMR Larimar Therapeutics, Inc. | 13G | 7.78% | Dec 31, 2023 | 2y |
| Empyrean Capital Partners, LP | AEON AEON Biopharma, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| ArrowMark Colorado Holdings LLC | CCSI Consensus Cloud Solutions, Inc. | 13G/A | 13.6% | Dec 31, 2023 | 2y |
| Alger Associates, Inc. 13-3017981 | NTRA Natera, Inc. | 13G/A | 5.9% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | XMTR Xometry, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | CLOE Clover Leaf Capital Corp. Class A Common Stock | 13G | 5.43% | Dec 31, 2023 | 2y |
| ALLIANCEBERNSTEIN L.P. | PBHC Pathfinder Bancorp, Inc. | 13G | 5.1% | Dec 31, 2023 | 2y |
| AQR CAPITAL MANAGEMENT LLC | CLRCF ClimateRock | 13G/A | 1.06% | Dec 31, 2023 | 2y |
| Dapice Joshua J. | FBRX Forte Biosciences, Inc. | 13G/A | 9.9% | Dec 31, 2023 | 2y |
| BIOTECHNOLOGY VALUE FUND L P | ARAV Aravive, Inc. Common Stock | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | SAIA Saia Inc | 13G/A | 7.4% | Dec 31, 2023 | 2y |
| MEGACHIPS CORP /FI | SITM SITIME Corp | 13G/A | 20.7% | Dec 31, 2023 | 2y |
| Technology Crossover Management IX, Ltd. | LZ Legalzoom.Com, Inc. | 13G/A | 8.7% | Dec 31, 2023 | 2y |
| JANUS HENDERSON GROUP PLC | CBAY Cymabay Therapeutics | 13G | 5.4% | Dec 31, 2023 | 2y |
| Bradley C. Beasley | BBGI Beasley Broadcast Group Inc | 13G/A | 9.2% | Dec 31, 2023 | 2y |
| Hood River Capital Management LLC | DCGO DocGo Inc. | 13G/A | 5.87% | Dec 31, 2023 | 2y |
| SIT INVESTMENT ASSOCIATES INC | SRV NXG Cushing Midstream Energy Fund | 13G | 8.46% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | ELMES Elme Communities | 13G/A | 0% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | BPOP Popular, Inc. | 13G | 5.9% | Dec 31, 2023 | 2y |
| Caledonia (Private) Investments Pty Ltd | RSVR Reservoir Media, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Thomas F. Knight Jr. | DNA Ginkgo Bioworks Holdings, Inc. | 13G/A | 4.1% | Dec 31, 2023 | 2y |
| Oasis Management Co Ltd. | PEGR Project Energy Reimagined Acquisition Corp. Class A Ordinary Share | 13G/A | 0% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | STEX Streamex Corp. | 13G | 6.36% | Dec 31, 2023 | 2y |
| Newtyn Management, LLC | CYT Cyteir Therapeutics, Inc. Common Stock | 13G | 8.4% | Dec 31, 2023 | 2y |
| ALLIANCEBERNSTEIN L.P. | HP Helmerich & Payne, Inc. | 13G/A | 0.6% | Dec 31, 2023 | 2y |
| Langley Steinert | CARG CarGurus, Inc. | 13G/A | 13% | Dec 31, 2023 | 2y |
| Strategic Value Investors LP | WNEB Western New England Bancorp, Inc. | 13G/A | 5.3% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | FWONA Liberty Media Corp | 13G/A | 3.9% | Dec 31, 2023 | 2y |
| M3 Funds, LLC | SNFCA Security National Financial Corp | 13G/A | 9% | Dec 31, 2023 | 2y |